Research Analysts' Weekly Ratings Changes for NovoCure (NVCR)

A number of firms have modified their ratings and price targets on shares of NovoCure (NASDAQ: NVCR) recently: 8/17/2023 – NovoCure is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 8/8/2023 – NovoCure was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They […]

Related Keywords

United States ,Japan ,China ,Leerink Partnrs ,Piper Sandler ,Optune Lua ,Blair William Co ,Dimensional Fund Advisors ,Wells Fargo Company ,Us Bancorp ,Blackrock Inc ,Panagora Asset Management Inc ,News Ratings For Novocure Limited Daily ,Wells Fargo ,Cure Stock Down ,Cure Limited ,Get Free Report ,Novocure Limited ,Asset Management ,Fund Advisors ,Blair William ,Middle East ,Novocure Limited Daily ,Nasdaq Nvcr ,Nvcr ,